MX9702149A - Medicamentos. - Google Patents

Medicamentos.

Info

Publication number
MX9702149A
MX9702149A MX9702149A MX9702149A MX9702149A MX 9702149 A MX9702149 A MX 9702149A MX 9702149 A MX9702149 A MX 9702149A MX 9702149 A MX9702149 A MX 9702149A MX 9702149 A MX9702149 A MX 9702149A
Authority
MX
Mexico
Prior art keywords
integer
medicaments
hydrogen
fluorocarbon
surfactant
Prior art date
Application number
MX9702149A
Other languages
English (en)
Inventor
Li Li-Bovet
Keith Arthur Johnson
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of MX9702149A publication Critical patent/MX9702149A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Abstract

La presente invencion se refiere a una formulacion en aerosol farmacéutica que comprende un medicamento particulado, un propulsor de fluorocarburo o de clorofluorocarburo que contiene hidrogeno y un agente tensioactivo de la formula general (I), en donde n es un numero entero de 1 a 18; m es un numero entero de 0 a 17; y R1, R2 y R3 son cada uno independientemente un átomo de hidrogeno o un grupo alquilo con C1-4.
MX9702149A 1994-09-28 1995-09-27 Medicamentos. MX9702149A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419536A GB9419536D0 (en) 1994-09-28 1994-09-28 Medicaments
PCT/IB1995/000866 WO1996009816A1 (en) 1994-09-28 1995-09-27 Medicaments

Publications (1)

Publication Number Publication Date
MX9702149A true MX9702149A (es) 1998-04-30

Family

ID=10762008

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702149A MX9702149A (es) 1994-09-28 1995-09-27 Medicamentos.

Country Status (32)

Country Link
US (1) US5849265A (es)
EP (1) EP0783302B1 (es)
JP (1) JPH10506887A (es)
KR (1) KR100375469B1 (es)
CN (1) CN1084614C (es)
AP (1) AP742A (es)
AT (1) ATE187063T1 (es)
AU (1) AU707922B2 (es)
BG (1) BG62839B1 (es)
BR (1) BR9509108A (es)
CZ (1) CZ286356B6 (es)
DE (1) DE69513671T2 (es)
DK (1) DK0783302T3 (es)
EE (1) EE03380B1 (es)
ES (1) ES2140706T3 (es)
FI (1) FI971279A (es)
GB (1) GB9419536D0 (es)
GE (1) GEP20002140B (es)
GR (1) GR3032245T3 (es)
HU (1) HU221856B1 (es)
IS (1) IS1991B (es)
MD (1) MD1900C2 (es)
MX (1) MX9702149A (es)
NO (1) NO313658B1 (es)
NZ (1) NZ292995A (es)
OA (1) OA10603A (es)
PL (1) PL181453B1 (es)
RO (1) RO118564B1 (es)
RU (1) RU2157188C2 (es)
SK (1) SK281519B6 (es)
UA (1) UA47412C2 (es)
WO (1) WO1996009816A1 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
ES2193069T3 (es) * 1999-04-14 2003-11-01 Glaxo Group Ltd Formulacion farmaceutica en aerosol.
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
CO5310534A1 (es) * 2000-08-05 2003-08-29 Glaxo Group Ltd Nuevos derivados de androstano anti-inflamatorios
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
EP1318973A2 (en) 2000-09-22 2003-06-18 Glaxo Group Limited Novel alkanoic acid derivatives
GB0106046D0 (en) 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
CZ20032958A3 (en) * 2001-04-30 2004-03-17 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
EP1395604B1 (en) * 2001-06-12 2008-06-25 Glaxo Group Limited Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds
ATE373469T1 (de) * 2001-08-03 2007-10-15 Glaxo Group Ltd Oberflächenaktive verbindungen und ihre anwendungen
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
EP1474376A1 (en) * 2002-02-13 2004-11-10 Glaxo Group Limited Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP2275479A1 (en) 2003-08-11 2011-01-19 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
CA2536876A1 (en) 2003-08-29 2005-03-17 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
US7030255B2 (en) * 2004-03-09 2006-04-18 Lyondell Chemical Technology, L.P. Oxidation process with in-situ H202 generation and polymer-encapsulated catalysts therefor
EP1949891A1 (en) 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
ATE404186T1 (de) * 2004-10-12 2008-08-15 Generics Uk Ltd Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
EP0478686B1 (en) * 1989-06-22 1993-08-11 Applications Et Transferts De Technologies Avancees Atta Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
WO1991014422A1 (en) * 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
JPH05509085A (ja) * 1990-06-27 1993-12-16 ミネソタ　マイニング　アンド　マニュファクチャリング　カンパニー 投与量が計測されたエーロゾル配合物の製造のための可溶性フルオロ界面活性剤の使用
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations

Also Published As

Publication number Publication date
ATE187063T1 (de) 1999-12-15
IS4438A (is) 1997-03-10
ES2140706T3 (es) 2000-03-01
EP0783302A1 (en) 1997-07-16
SK281519B6 (sk) 2001-04-09
DE69513671D1 (de) 2000-01-05
AP742A (en) 1999-04-26
EP0783302B1 (en) 1999-12-01
SK39397A3 (en) 1997-10-08
GR3032245T3 (en) 2000-04-27
RU2157188C2 (ru) 2000-10-10
RO118564B1 (ro) 2003-07-30
CN1168630A (zh) 1997-12-24
EE03380B1 (et) 2001-04-16
DE69513671T2 (de) 2000-04-06
AU707922B2 (en) 1999-07-22
OA10603A (en) 2002-08-30
EE9700061A (et) 1997-08-15
NO971422D0 (no) 1997-03-25
CZ286356B6 (cs) 2000-03-15
AP9700951A0 (en) 1997-04-30
NZ292995A (en) 1998-10-28
MD1900C2 (ro) 2002-12-31
WO1996009816A1 (en) 1996-04-04
DK0783302T3 (da) 2000-05-29
BG62839B1 (bg) 2000-09-29
NO313658B1 (no) 2002-11-11
FI971279A0 (fi) 1997-03-26
CN1084614C (zh) 2002-05-15
HU221856B1 (hu) 2003-02-28
AU3532195A (en) 1996-04-19
GEP20002140B (en) 2000-06-25
NO971422L (no) 1997-05-23
KR970705981A (ko) 1997-11-03
HUT77377A (hu) 1998-04-28
PL319342A1 (en) 1997-08-04
BR9509108A (pt) 1998-07-14
IS1991B (is) 2005-02-15
UA47412C2 (uk) 2002-07-15
GB9419536D0 (en) 1994-11-16
BG101347A (en) 1997-12-30
MD970134A (en) 1999-02-28
CZ93697A3 (en) 1997-08-13
MD1900B2 (en) 2002-04-30
KR100375469B1 (ko) 2003-10-17
FI971279A (fi) 1997-03-26
PL181453B1 (pl) 2001-07-31
JPH10506887A (ja) 1998-07-07
US5849265A (en) 1998-12-15

Similar Documents

Publication Publication Date Title
MX9702149A (es) Medicamentos.
GR3017611T3 (en) Propellant compositions.
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
AU6809090A (en) Bicyclam derivatives
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
CA2238553A1 (en) Cholesterol-lowering composition
DK0918507T3 (da) Aerosolformuleringer
DE69533190D1 (de) Behandlung von pulmonaler vasokonstriktion und asthma
BG103221A (en) Pharmaceutical composition in aerosol form
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DK0654991T3 (da) Inhalationspulver indeholdende antistatisk hjælpemiddel
ZA8410021B (en) 11beta-arylestradienes,their production,and pharmaceutical preparations containing same
PL341055A1 (en) Novel form of a drug for oral administration of active compounds being unstable in acid environments
AU4346996A (en) Pharmaceutical aerosol containing at least one sugar
GEP20012439B (en) Aniline Derivatives Having Nitrogen Monoxide Synthase Inhibitory Activity and Pharmaceutical Compositions Containing the Same
AU1220192A (en) Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them
EP0322182A3 (en) Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
GB2332372B (en) Pharmaceutical aerosol compositions
GB0016876D0 (en) Novel formulation
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
WO1993013739A3 (en) Retroreverse pyrrole-amidino oligopeptide anticancer agent analogues, preparation of same, and pharmaceutical compositions containing such analogues
CA2200986A1 (en) Medicaments
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
NZ243784A (en) N-(isoquinolin-5-ylsulphonyl) azacycloalkane derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: SMITHKLINE BEECHAM CORPORATION

MM Annulment or lapse due to non-payment of fees